| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 2515530
[patent_doc_number] => 04874697
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1989-10-17
[patent_title] => 'Novel Host e. coli and use thereof'
[patent_app_type] => 1
[patent_app_number] => 6/947398
[patent_app_country] => US
[patent_app_date] => 1986-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3384
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/874/04874697.pdf
[firstpage_image] =>[orig_patent_app_number] => 947398
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/947398 | Novel Host e. coli and use thereof | Dec 28, 1986 | Issued |
Array
(
[id] => 2487566
[patent_doc_number] => RE032833
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1989-01-17
[patent_title] => 'Screening vaccines and immunization process'
[patent_app_type] => 2
[patent_app_number] => 7/004172
[patent_app_country] => US
[patent_app_date] => 1986-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3929
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/032/RE032833.pdf
[firstpage_image] =>[orig_patent_app_number] => 004172
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/004172 | Screening vaccines and immunization process | Dec 22, 1986 | Issued |
Array
(
[id] => 2619624
[patent_doc_number] => 04894330
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1990-01-16
[patent_title] => 'Purification of recombinant beta-interferon incorporating RP-HPLC'
[patent_app_type] => 1
[patent_app_number] => 6/946083
[patent_app_country] => US
[patent_app_date] => 1986-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13469
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/894/04894330.pdf
[firstpage_image] =>[orig_patent_app_number] => 946083
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/946083 | Purification of recombinant beta-interferon incorporating RP-HPLC | Dec 22, 1986 | Issued |
Array
(
[id] => 2503358
[patent_doc_number] => 04798789
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1989-01-17
[patent_title] => 'cDNA clones coding for polypeptides exhibiting murine interleukin-2 activity'
[patent_app_type] => 1
[patent_app_number] => 6/942600
[patent_app_country] => US
[patent_app_date] => 1986-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 10806
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/798/04798789.pdf
[firstpage_image] =>[orig_patent_app_number] => 942600
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/942600 | cDNA clones coding for polypeptides exhibiting murine interleukin-2 activity | Dec 16, 1986 | Issued |
Array
(
[id] => 2625593
[patent_doc_number] => 04915941
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1990-04-10
[patent_title] => 'Method for preventing the development or decreasing the extent of malarial parasitemia'
[patent_app_type] => 1
[patent_app_number] => 6/940510
[patent_app_country] => US
[patent_app_date] => 1986-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5201
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/915/04915941.pdf
[firstpage_image] =>[orig_patent_app_number] => 940510
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/940510 | Method for preventing the development or decreasing the extent of malarial parasitemia | Dec 10, 1986 | Issued |
| 06/935123 | METHOD FOR PREPARING A PURIFIED EXTRACTION RESIDUE FRACTION AND ITS USE IN STIMULATING THE IMMUNE RESPONSE | Nov 25, 1986 | Abandoned |
Array
(
[id] => 2508508
[patent_doc_number] => 04851219
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1989-07-25
[patent_title] => 'Method for the treatment of chronic myelogenous leukemia'
[patent_app_type] => 1
[patent_app_number] => 6/932434
[patent_app_country] => US
[patent_app_date] => 1986-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1888
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/851/04851219.pdf
[firstpage_image] =>[orig_patent_app_number] => 932434
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/932434 | Method for the treatment of chronic myelogenous leukemia | Nov 17, 1986 | Issued |
Array
(
[id] => 2617642
[patent_doc_number] => 04894226
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1990-01-16
[patent_title] => 'Solubilization of proteins for pharmaceutical compositions using polyproline conjugation'
[patent_app_type] => 1
[patent_app_number] => 6/931197
[patent_app_country] => US
[patent_app_date] => 1986-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9202
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/894/04894226.pdf
[firstpage_image] =>[orig_patent_app_number] => 931197
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/931197 | Solubilization of proteins for pharmaceutical compositions using polyproline conjugation | Nov 13, 1986 | Issued |
| 06/927834 | TREATMENT OF IMMUNO-RESISTANT DISEASE | Nov 5, 1986 | Abandoned |
Array
(
[id] => 2524319
[patent_doc_number] => 04797279
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1989-01-10
[patent_title] => 'Insecticidal hybrid bacteria from b.t. kurstaki and b.t. tenebrionis'
[patent_app_type] => 1
[patent_app_number] => 6/924372
[patent_app_country] => US
[patent_app_date] => 1986-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2309
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/797/04797279.pdf
[firstpage_image] =>[orig_patent_app_number] => 924372
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/924372 | Insecticidal hybrid bacteria from b.t. kurstaki and b.t. tenebrionis | Oct 27, 1986 | Issued |
| 06/923423 | PHARMACEUTICAL COMPOSITIONS OF RECOMBINANT BETA-INTERFERON AND FORMULATION PROCESSES | Oct 26, 1986 | Abandoned |
| 06/921214 | RECOMBINANT HERPES SIMPLEX GD VACCINE | Oct 19, 1986 | Abandoned |
| 06/921213 | RECOMBINANT HERPES SIMPLEX GB-GD VACCINE | Oct 19, 1986 | Abandoned |
Array
(
[id] => 2489804
[patent_doc_number] => 04828990
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1989-05-09
[patent_title] => 'Method for purifying an interferon'
[patent_app_type] => 1
[patent_app_number] => 6/908707
[patent_app_country] => US
[patent_app_date] => 1986-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8999
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/828/04828990.pdf
[firstpage_image] =>[orig_patent_app_number] => 908707
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/908707 | Method for purifying an interferon | Oct 9, 1986 | Issued |
Array
(
[id] => 2621338
[patent_doc_number] => 04950470
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1990-08-21
[patent_title] => 'Methods and compositions employing interferon-gamma'
[patent_app_type] => 1
[patent_app_number] => 6/916008
[patent_app_country] => US
[patent_app_date] => 1986-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 12193
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/950/04950470.pdf
[firstpage_image] =>[orig_patent_app_number] => 916008
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/916008 | Methods and compositions employing interferon-gamma | Oct 5, 1986 | Issued |
Array
(
[id] => 2486066
[patent_doc_number] => 04868118
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1989-09-19
[patent_title] => 'Cloning and expression of the 47-kilodalton antigen of treponema pallidum'
[patent_app_type] => 1
[patent_app_number] => 6/913724
[patent_app_country] => US
[patent_app_date] => 1986-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8896
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/868/04868118.pdf
[firstpage_image] =>[orig_patent_app_number] => 913724
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/913724 | Cloning and expression of the 47-kilodalton antigen of treponema pallidum | Sep 29, 1986 | Issued |
| 06/912485 | COMPOSITION FOR PREVENTING AND TREATING PROLIFERATIVE DISEASES, AND VIRAL INFECTIONS NEOPLASTIC GROWTH AND METASTASIS | Sep 28, 1986 | Abandoned |
Array
(
[id] => 2652878
[patent_doc_number] => 04929442
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1990-05-29
[patent_title] => 'Compositions suitable for human topical application including a growth factor and/or related materials'
[patent_app_type] => 1
[patent_app_number] => 6/912828
[patent_app_country] => US
[patent_app_date] => 1986-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4320
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 150
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/929/04929442.pdf
[firstpage_image] =>[orig_patent_app_number] => 912828
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/912828 | Compositions suitable for human topical application including a growth factor and/or related materials | Sep 25, 1986 | Issued |
Array
(
[id] => 2514107
[patent_doc_number] => 04851512
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1989-07-25
[patent_title] => 'Novel human interleukin-2 polypeptide derivative'
[patent_app_type] => 1
[patent_app_number] => 6/911811
[patent_app_country] => US
[patent_app_date] => 1986-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4928
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/851/04851512.pdf
[firstpage_image] =>[orig_patent_app_number] => 911811
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/911811 | Novel human interleukin-2 polypeptide derivative | Sep 25, 1986 | Issued |
Array
(
[id] => 2516566
[patent_doc_number] => 04874750
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1989-10-17
[patent_title] => 'Pharmaceutical composition containing a derivative of para-aminobenzoic acid as an active ingredient'
[patent_app_type] => 1
[patent_app_number] => 6/908273
[patent_app_country] => US
[patent_app_date] => 1986-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 8
[patent_no_of_words] => 7337
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/874/04874750.pdf
[firstpage_image] =>[orig_patent_app_number] => 908273
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/908273 | Pharmaceutical composition containing a derivative of para-aminobenzoic acid as an active ingredient | Sep 16, 1986 | Issued |